welcome to DuchenneXchange- a positively charged Duchenne muscular dystrophy community.
- join today!
George Dickson, PhD
Professor of Molecular Cell Biology
Centre for Biomedical Sciences
Royal Holloway - University of London
Surrey, United Kingdom
George Dickson is Professor of Molecular Cell Biology at Royal Holloway, University of London (RHUL). He has spent most of his career studying neuromuscular disease and muscle cell biology, including the first cloning of an intact dystrophin gene, the discovery of the role of cell adhesion molecules in muscle stem cell fusion, the first identification of utrophin, and the first description of exon skipping in Duchenne muscular dystrophy (DMD). He is a member of various consortiums and projects of gene therapy. He is a past President of the European Society of Gene & Cell Therapy, and a past Secretary and founder member of the British Society for Gene Therapy.
His present research includes optimisation of exon-skipping and antisense oligonucleotide formulations for DMD, inhibition of myostatin by RNA skipping and gene therapy for DMD, development of dystrophin minigenes and AAV viral vectors for treatment of DMD, direct genome correction of DMD using endonuclease-mediated genome surgery and general muscle fibre and stem cell biology.
Barry J. Byrne, MD, PhDDr. Barry J. Byrne is a clinician scient...
Joline Dalton, MS, CGCJoline Dalton is a board certified genet...
Bespoke Is Often Better: How Scientists Are Customizing Gene TherapyWhen it comes to products from suits to ...
Katherine Bushby, MD, FRCPKatherine Bushby (retired) has a long-st...
Ann Martin, MS, CGCAnn Martin, MS, CGC is a certified genet...
Sarepta Therapeutics Announces that Phase 1/2a Duchenne Muscular Dystrophy (DMD) Micro-Dystrophin Gene Therapy Trial...Sarepta Therapeutics, Inc., a commercia...
Kristin Engelstad, MS, CGCKristin Engelstad is a clinical study co...